Key facts
- This page summarizes Jeffrey Sagansky's Form 4 filing for Sharecare, Inc..
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 25 Oct 2024, 06:08.
Jeffrey Sagansky - 22 Oct 2024 Form 4 Insider Report for Sharecare, Inc.
- Reporting relationship
- Director
- Issuer ticker
- N/A
- Reported as of
- 22 Oct 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 25 Oct 2024, 06:08:45 UTC
- Prior SEC filing
- 18 Jun 2024
- Next SEC filing
- 23 Oct 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Christie J. Miller, Attorney-in-Fact for Reporting Person
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Jeffrey Sagansky filed Form 4 for Sharecare, Inc. on 25 Oct 2024.
Change
- Previous filing in this sequence was filed on 18 Jun 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
SHCR
transaction
Common Stock
Disposed to Issuer
- Transaction value
- Shares
- -927,011
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 22 Oct 2024
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
SHCR
transaction
Derivative
Restricted Stock Units
Disposed to Issuer
- Transaction value
- $0
- Shares
- -328,720
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 22 Oct 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 328,720
- Exercise price
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
Jeffrey Sagansky is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 2 footnotes
Footnote F1
Pursuant to the Agreement and Plan of Merger, dated as of June 21, 2024 (the "Merger Agreement"), by and among Sharecare, Inc. ("Sharecare"), Impact Acquiror Inc., a Delaware corporation ("Parent") and Impact Merger Sub Inc., a Delaware corporation and a wholly owned subsidiary of Parent ("Merger Sub"), Merger Sub merged with and into the Company (the "Merger"), with the Company surviving the Merger as a wholly owned subsidiary of Parent. At the effective time of the Merger (the "Effective Time"), each share of Sharecare common stock, par value $0.0001 ("Company Common Stock"), reported in this row was converted into the right to receive a cash payment (without interest and subject to applicable taxes) equal to the per share merger consideration of $1.43 (the "Merger Consideration"). As a result of the Merger, Reporting Person no longer beneficially owns, directly or indirectly, any shares of Company Common Stock.
Footnote F2
Pursuant to the Merger Agreement, at the Effective Time, each outstanding restricted stock unit of Reporting Person ("Company RSU Award") was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product of multiplying (A) the number of shares of Company Common Stock subject to the Company RSU Award immediately prior to the Effective Time by (B) the Merger Consideration.